Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 USD | +6.35% | +13.73% | +54.07% |
14/05 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
12/04 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.07% | 94Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+1.46% | 2.23TCr | |
-12.64% | 2.22TCr | |
-5.10% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- Earnings Flash (NRIX) NURIX THERAPEUTICS Reports Q1 Revenue $16.6M